Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,315
-$307 QoQ
Shares Held
327
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#141
of 164 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ramirez Asset Management, Inc. holds $30,805,111 across 7 Drug Manufacturers - General names. GRFS ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,509 | $18,601,961 | |
| 2 | ABBV |
AbbVie Inc.
|
23,922 | $6,019,732 | |
| 3 | AZN |
Astrazeneca PLC
|
30,192 | $5,725,007 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,016 | $289,021 | |
| 5 | JNJ |
Johnson & Johnson
|
626 | $158,985 | |
| 6 | PFE |
Pfizer Inc
|
336 | $8,090 | |
| 7 | GRFS |
Grifols SA
This page
|
327 | $2,315 |
All Filings in GRFS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,315 | 327 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,622 | 327 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,057 | 327 | Shares | Sole | 2026-02-11 | |
| 2024-06-30 | $330,479 | 52,374 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $404,834 | 60,604 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $553,284 | 47,862 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $445,931 | 48,789 | Shares | Sole | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||